-
Scandic Trust Group strengthens sales network with First Idea Consultant
-
Green shines as Suns thump Clippers 115-102
-
Japan to screen #MeToo film months after Oscar nomination
-
Erasmus relishing 'brutal' France re-match on Paris return
-
Rejuvenated Vlahovic taking the reins for Juve ahead of Turin derby
-
'Well-oiled' Leipzig humming along in Bayern's slipstream
-
Bangladesh cricket probes sexual harassment claims
-
NFL-best Broncos edge Raiders to win seventh in a row
-
Deadly Typhoon Kalmaegi ravages Vietnam, Philippines
-
Three killed in new US strike on alleged drug boat, toll at 70
-
Chinese microdrama creators turn to AI despite job loss concerns
-
Trump hails Central Asia's 'unbelievable potential' at summit
-
Kolya, the Ukrainian teen preparing for frontline battle
-
Big leap in quest to get to bottom of climate ice mystery
-
Markets drop as valuations and US jobs, rates spook investors
-
'Soap opera on cocaine': how vertical dramas flipped Hollywood
-
Under pressure? EU states on edge over migrant burden-sharing
-
US influencers falsely associate Mamdani with extremist group
-
Hungary's Orban to meet Trump in face of Russia oil sanctions
-
US facing travel chaos as flights cut due to govt shutdown
-
Liverpool and Man City renew rivalry as they try to narrow Arsenal gap
-
UK's Andrew asked to testify over Epstein as he formally loses titles
-
Local hero: 'DC sandwich guy' found not guilty of assaulting officer with sub
-
Dead famous: Paris puts heritage graves up for grabs
-
UK grandmother on Indonesia death row flies home
-
Former NFL star Brown extradited from Dubai to face trial in shooting - police
-
How to Sell Your Small Business Fast (Guide Release)
-
Chile presidential hopeful vows to expel 'criminal' migrants to El Salvador
-
Trump event paused in Oval Office when guest faints
-
NFL Colts add Sauce to recipe while Patriots confront Baker
-
Home owned by Miami Heat coach Spoelstra damaged by fire
-
Tesla shareholders approve Musk's $1 trillion pay package
-
World leaders launch fund to save forests, get first $5 bn
-
Villa edge Maccabi Tel Aviv in fraught Europa League match
-
Protests as Villa beat Maccabi Tel Aviv under tight security
-
US Supreme Court backs Trump admin's passport gender policy
-
Japan boss Jones backs Farrell to revive Ireland's fortunes
-
MLB Padres name former reliever Stammen new manager
-
'Grand Theft Auto VI' video game delayed again until Nov. 2026
-
Martino returns as head coach of MLS Atlanta United
-
Hamilton dismisses Ferrari exit claims
-
Musetti keeps ATP Finals hopes alive, joins Djokovic in Athens semis
-
England boss Borthwick wants 'brilliant' Marcus Smith to shine against Fiji
-
Piastri says he is confident he can recover and win drivers' title
-
Verstappen admits he may need a bit of 'luck' to haul in rivals in title race
-
Kazakhstan to join Abraham Accords as Trump pushes Mideast peace
-
'Moral failure': Leaders seek to rally world at Amazon climate talks
-
UN Security Council votes to lift sanctions on Syrian president
-
Democratic giant, trailblazer and Trump foe Nancy Pelosi to retire
-
World leaders ditch ties at sweaty climate summit
The suffering of those who cannot feel pain
Patrice Abela first knew something was wrong when his eldest daughter was learning to walk and her feet left trails of blood behind her, yet she showed no sign of distress.
She was soon diagnosed with congenital insensitivity to pain, an extremely rare and dangerous genetic disorder that dooms sufferers to a lifetime of hurting themselves in ways they cannot feel.
Abela, a 55-year-old software developer in the southern French city of Toulouse, then watched in horror as his youngest daughter was revealed to have the same condition.
Now aged 12 and 13, the two girls spend around three months of every year in hospital.
"When they take a shower, they perceive hot and cold, but if it burns they don't feel anything," the father of four told AFP.
"Due to repeated infections, my eldest daughter lost the first joint of each of her fingers. She also had to have a toe amputated."
Repeated knee injuries have left both girls only able to move around using crutches or a wheelchair.
Abela said they may not feel physical pain but lamented their intense "psychological pain".
Aiming to raise awareness about the disease and "challenge the scientific community", Abela plans to run the equivalent of 90 marathons in fewer than four months. He plans to start on April 12, following the route of this year's Tour de France from Copenhagen to Paris.
- Danger everywhere -
A life without pain might sound like a dream come true but the reality is more like a nightmare.
There are only a few thousand known cases of the condition worldwide. The low number is believed to be partly due to sufferers often not living into adulthood.
"Pain plays a major physiological role in protecting us from the dangers of our environment," said Didier Bouhassira, a doctor at the centre for pain evaluation and treatment at Ambroise-Pare hospital in Paris.
In the most extreme cases, babies will "mutilate their tongue or fingers while teething", he told AFP.
Then comes "a lot of accidents, burns, walking on fractured limbs which heal badly", he added.
"They have to be taught what is innate in others: to protect themselves."
But when there are no warning signs, danger lurks everywhere.
Appendicitis, which announces itself in others via symptoms like pain and fever, can fester into a devastating general infection of the abdomen.
"Blindness can also occur because the eye must always be kept moist and the nervous system controls these processes via the so-called blink reflex," said Ingo Kurth of Germany's Institute of Human Genetics.
- New painkiller hopes -
Congenital insensitivity to pain (CIP) was first recognised in the 1930s, and numerous studies have since identified a genetic mutation that blocks a person's ability feel pain.
"We have learned that there are now more than 20 genetic causes of congenital or progressive insensitivity to pain," Kurth told AFP.
There is no cure and "no real drug breakthroughs have been made so far", Kurth said.
"But our understanding of the molecular causes of CIP continues to reveal new targets, and based on this, hopefully new therapies will be developed in the coming years."
There are also hopes that studying how CIP works could lead to the development of a new kind of painkiller, prompting huge interest from pharmaceutical giants seeking a fresh product in the billion-dollar industry of pain relief.
In this way, the unlucky few with CIP could contribute to the creation of a treatment that would help everyone in the world -- except themselves.
P.Stevenson--AMWN